CDRH maintains their commitment to partnering with patients in their 2016-17 strategic priorities, cites involvement with the PCBR Framework
U.S. FDA commissioner nominee Robert Califf, MD, in written comments to the Senate, cites MDIC as an example of a public-private partnership that has been highly successful in promoting multi-sector dialogue
RAPS Regulatory Focus features an article by MDIC Board member Ross Jaffe, MDIC President & CEO Bill Murray, MDIC program manager Stephanie Christopher and CDRH staff Katie O’Callaghan and Annie Saha that highlights the MDIC Patient Centered Benefit-Risk Framework as a model of the regulatory science research possible in public-private partnerships
RAPS Regulatory Focus features an article by MDIC Board member Ross Jaffe, MDIC President & CEO Bill Murray, MDIC program manager Stephanie Christopher and CDRH staff Katie O’Callaghan and Annie Saha that highlights the MDIC Patient Centered Benefit-Risk Framework as a model of the regulatory science research possible in public-private partnerships
The December Journal of Healthcare Contracting introduces supply chain leaders to the Case for Quality and the collaborative’s transformative potential. “If, as a medical technology community, we can agree on defined quality metrics that feed information back into the design and manufacturing process, we will reduce problems, reduce costs, and pass on the benefits to the consumer,” says CfQ Program Manager Dwight Abouhalkah
The latest Case for Quality Open Forum Presentations are available here
Fierce Heath IT highlighted the recent JAMA editorial by FDA Deputy Commissioner Dr. Rob Califf which highlights FDA’s collaboration with MDIC on the development of the patient preference Framework and Catalog
Fierce Heath IT highlighted the recent JAMA editorial by FDA Deputy Commissioner Dr. Rob Califf which highlights FDA’s collaboration with MDIC on the development of the patient preference Framework and Catalog
JAMA editorial on patient engagement across the spectrum of medical device development by FDA authors including Deputy Commissioner Dr. Rob Califf highlights FDA’s collaboration with MDIC on the patient preference Framework and Catalog